[Edaily Reporter Kwon Oh-seok] #Famtech’s stock price has surged for four consecutive trading days on the back of news regarding its acquisition of a wafer robot company.
Famtech According to MP Doctor on the 5th, as of 9:20 a.m., Famtech is trading at 2,730 won, up 15.68% from the previous trading day. Previously, on the 1st, Famtech announced that it had acquired 100% of the shares in TIS, a company specializing in industrial robots, to expand its semiconductor process automation equipment business. As a result, the stock closed at the daily price limit for three consecutive trading days from that day until the previous day (the 4th). Famtech plans to internalize TIS’s technology to advance its existing semiconductor logistics automation equipment business, including EFEM (Equipment Front End Module) and sorters. Additionally, the company aims to secure a leading position in the glass substrate automation equipment market by combining its in-house automation equipment design and manufacturing capabilities with TIS’s precision robot handling technology. With the growing importance of advanced packaging technologies driven by the recent proliferation of artificial intelligence (AI) and high-performance computing (HPC), glass substrates are gaining attention as next-generation semiconductor materials. Glass substrates come in a wider variety of sizes and thicknesses than traditional wafers, making precision transfer and alignment technologies essential.
The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…